The US Food and Drug Administration has approved another once-a-day pill that works without hormones to treat moderate to severe hot flashes in menopausal women, drugmaker Bayer said Friday.

According to the Minister, the tool is “an investment in the power of data to save lives. Our political will to end TB is ...

Tuberculosis (TB) remains the world's leading cause of death from a single infectious agent. A new study recently published ...

The FDA approved nerandomilast (Jascayd) tablets for idiopathic pulmonary fibrosis (IPF), the first new product for the progressive lung condition in over a decade, the agency announced on Tuesday.

A new study projects that US funding cuts to global health aid will have a catastrophic effect on pediatric TB, with children ...

With regard to respiratory tuberculosis-related deaths from 1999 to 2020, common populations included older adults, males and racial minorities, according to data presented at the CHEST Annual Meeting ...

Since the 1940s, antibiotics have been our primary weapon against harmful bacterial infections. But some stubborn pathogens, ...

The World Health Organization has updated its TB guidelines, now recognizing nutrition as a core component of treatment.

WhiteSands Alcohol & Drug Rehab has released a new educational resource titled “Why Is Early Intervention Important for Recovery?“, now available on their website. The article examines how timely ...

More than 10 years after bringing one of the first idiopathic pulmonary fibrosis (IPF) drugs to market, Boehringer Ingelheim is freshening up its leadership in the rare lung disease space with a newly ...